Kidney health for everyone everywhere—from prevention to detection and equitable access to care
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Around 850 million people currently are affected by different types of kidney disorders.1International Society of Nephrology2019 United Nations High Level Meeting on UHC: Moving Together to Build Kidney Health worldwide; 2019.https://www.theisn.org/images/Advocacy_4_pager_2019_Final_WEB_pagebypage.pdfDate accessed: July 20, 2019Google Scholar Up to 1 in 10 adults worldwide has chronic kidney disease (CKD), which is invariably irreversible and mostly progressive. The global burden of CKD is increasing, and CKD is projected to become the fifth most common cause of years of life lost globally by 2040.2Foreman K.J. Marquez N. Dolgert A. et al.Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories.Lancet. 2018; 392: 2052-2090Abstract Full Text Full Text PDF PubMed Scopus (465) Google Scholar If CKD remains uncontrolled and if the affected person survives the ravages of cardiovascular and other complications of the disease, CKD progresses to end-stage kidney disease, where life cannot be sustained without dialysis therapy or kidney transplantation. Hence, CKD is a major cause of catastrophic health expenditure.3Essue B.M. Laba T.L. Knaul F. et al.Economic burden of chronic ill health and injuries for households in low- and middle-income countries.in: Jamison D.T. Gelband H. Horton S. Disease Control Priorities Improving Health and Reducing Poverty. 3rd ed. World Bank, Washington, DC2018: 121-143Google Scholar The costs of dialysis and transplantation consume 2%–3% of the annual health care budget in high-income countries, spent on less than 0.03% of the total population of these countries.4Vanholder R. Annemans L. Brown E. et al.Reducing the costs of chronic kidney disease while delivering quality health care: a call to action.Nat Rev Nephrol. 2017; 13: 393-409Crossref PubMed Scopus (109) Google Scholar Importantly, however, kidney disease can be prevented and progression to end-stage kidney disease can be delayed with appropriate access to basic diagnostics and early treatment including lifestyle modifications and nutritional interventions.4Vanholder R. Annemans L. Brown E. et al.Reducing the costs of chronic kidney disease while delivering quality health care: a call to action.Nat Rev Nephrol. 2017; 13: 393-409Crossref PubMed Scopus (109) Google Scholar, 5Luyckx V.A. Tuttle K.R. Garcia-Garcia G. et al.Reducing major risk factors for chronic kidney disease.Kidney Int Suppl (2011). 2017; 7: 71-87Abstract Full Text Full Text PDF PubMed Scopus (95) Google Scholar, 6Luyckx V.A. Tonelli M. Stanifer J.W. The global burden of kidney disease and the sustainable development goals.Bull World Health Organ. 2018; 96: 414-422DCrossref PubMed Scopus (221) Google Scholar, 7Tonelli M. Muntner P. Lloyd A. et al.Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study.Lancet. 2012; 380: 807-814Abstract Full Text Full Text PDF PubMed Scopus (470) Google Scholar, 8Kalantar-Zadeh K. Fouque D. Nutritional management of chronic kidney disease.N Engl J Med. 2017; 377: 1765-1776Crossref PubMed Scopus (213) Google Scholar Despite this access to effective and sustainable health care provision programs, kidney care remains highly inequitable across the world. Indeed, of parallel importance is the ongoing health inequity in CKD care including inequity of health care access particularly among some of the indigenous populations in certain regions of the world, and this may have a bearing on the preexisting and emerging health gaps between low-middle-income, middle-income, and high-income countries. Kidney disease is crucially missing from the international agenda for global health. It is notably absent from the impact indicators for the Sustainable Development Goal Goal 3, Target 3.4, “By 2030, reduce by one third premature mortality from noncommunicable diseases (NCDs) through prevention and treatment and promote mental health and well-being,” and the latest iteration of the United Nations Political Declaration on NCDs.9United Nations General AssemblyPolitical declaration of the third high-level meeting of the General Assembly on the prevention and control ofnon-communicable diseases; 2018.https://www.un.org/ga/search/view_doc.asp?symbol=A/73/L.2&Lang=EDate accessed: November 3, 2019Google Scholar CKD is a major risk factor for heart disease and cardiac death, as well as for infections such as tuberculosis, and is a major complication of other preventable and treatable conditions including diabetes, hypertension, HIV, and hepatitis.4Vanholder R. Annemans L. Brown E. et al.Reducing the costs of chronic kidney disease while delivering quality health care: a call to action.Nat Rev Nephrol. 2017; 13: 393-409Crossref PubMed Scopus (109) Google Scholar, 5Luyckx V.A. Tuttle K.R. Garcia-Garcia G. et al.Reducing major risk factors for chr
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Webster, A. C., Nagler, E. V., Morton, R. L., & Masson, P. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32064-5 · Cited by 3,842
Nutritional Management of Chronic Kidney Disease
Kalantar-Zadeh, K., & Fouque, D. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1700312 · Cited by 636
Self-citationEne-Iordache, B., Perico, N., Bikbov, B., Carminati, S., Remuzzi, A., Perna, A., Islam, N., Bravo, R. F., Aleckovic-Halilovic, M., Zou, H., et al. (2016) · The Lancet Global Health · doi:10.1016/s2214-109x(16)00071-1 · Cited by 627
Self-citationTesting for chronic kidney disease: a position statement from the National Kidney Foundation
Vassalotti, J. A., Stevens, L. A., & Levey, A. S. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.06.013 · Cited by 331
Cited by
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530
Self-citationKalantar-Zadeh, K., Jafar, T. H., Nitsch, D., Neuen, B. L., & Perkovic, V. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00519-5 · Cited by 1,461
Self-citationShlipak, M. G., Tummalapalli, S. L., Boulware, L. E., Grams, M. E., Ix, J. H., Jha, V., Kengne, A.-P., Madero, M., Mihaylova, B., Tangri, N., et al. (2021) · Kidney International · doi:10.1016/j.kint.2020.10.012 · Cited by 581
Jin, J., Wang, T., Park, W., Li, W., Kim, W., Park, S. K., & Kang, K. P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218184 · Cited by 43
Metadata
- Authors
- Li, P. K.-T., Garcia-Garcia, G., Lui, S.-F., Andreoli, S., Fung, W. W.-S., Hradsky, A., Kumaraswami, L., Liakopoulos, V., Rakhimova, Z., Saadi, G., Strani, L., Ulasi, I., Kalantar-Zadeh, K., Li, P. K. T., Garcia-Garcia, G., Andreoli, S., Kalantar-Zadeh, K., Kumaraswami, L., Liakopoulos, V., Lui, S.-F., Saadi, G., Strani, L., & Ulasi, I.
- Venue
- Kidney International
- Publisher
- Elsevier BV
- Published
- 2020-02
- Volume
- 97
- Issue
- 2
- Pages
- 226-232
- ISSN
- 0085-2538 (ISSN-L)
- OpenAlex
- W3001749284
- Cited by
- 110
- References
- 4
- FWCI
- 11.33
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Kidney health for everyone everywhere—from prevention to detection and equitable access to care. https://app.cochat.ai/papers/10.1016/j.kint.2019.12.002
- The paper
- Li, P. K.-T., Garcia-Garcia, G., Lui, S.-F., Andreoli, S., Fung, W. W.-S., Hradsky, A., Kumaraswami, L., Liakopoulos, V., Rakhimova, Z., Saadi, G., Strani, L., Ulasi, I., Kalantar-Zadeh, K., Li, P. K. T., Garcia-Garcia, G., Andreoli, S., Kalantar-Zadeh, K., Kumaraswami, L., Liakopoulos, V., . . . Ulasi, I. (2020). Kidney health for everyone everywhere—from prevention to detection and equitable access to care. Kidney International. https://doi.org/10.1016/j.kint.2019.12.002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.